Showing results (191-200 of 295) with videos related to
Sort By:
Pageof 30
Respiratory Medicine|February 21, 2015
Changes in fatigability following intense aerobic exercise training in patients with interstitial lung diseaseRandall E Keyser, Eric J Christensen, Lisa M K Chin, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 6, 2019
Single-center experience with use of letermovir for CMV prophylaxis or treatment in thoracic organ transplant recipientsShambhu Aryal, Shalika B Katugaha, Adam Cochrane, et al.Respiratory Medicine|July 16, 2008
Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosisSteven D Nathan, Oksana A Shlobin, Scott D Barnett, et al.Chest|August 28, 2012
Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertensionLeighton Chan, Lisa M K Chin, Michelle Kennedy, et al.Respiratory Medicine|May 10, 2015
Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosisSteven D Nathan, Roland M du Bois, Carlo Albera, et al.Chest|February 25, 2020
A Randomized, Double-Blind, Placebo-Controlled Study of Pulsed, Inhaled Nitric Oxide in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary FibrosisSteven D Nathan, Kevin R Flaherty, Marilyn K Glassberg, et al.European Respiratory Review : an Official Journal of the European Respiratory Society|December 8, 2017
Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosisLisa H Lancaster, Joao A de Andrade, Joseph D Zibrak, et al.Annals of the American Thoracic Society|August 14, 2024
Inhaled Nitric Oxide in Fibrotic Lung Disease: A Randomized, Double-Blind, Placebo-controlled TrialSteven D Nathan, Natasa Rajicic, Rosemarie Dudenhofer, et al.Pulmonary Circulation|April 19, 2021
Pulmonary hypertension due to interstitial lung disease or chronic obstructive pulmonary disease: a patient experience study of symptoms and their impact on quality of lifeHilary M DuBrock, Steven D Nathan, Bryce B Reeve, et al.Chest|November 26, 2018
Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary FibrosisSteven D Nathan, Ulrich Costabel, Ian Glaspole, et al.Pageof 30